Welcome to our dedicated news page for Mangoceuticals (Ticker: MGRX), a resource for investors and traders seeking the latest updates and insights on Mangoceuticals .
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Mangoceuticals 's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Mangoceuticals 's position in the market.
Rhea-AI Summary
Mangoceuticals, Inc. (NASDAQ: MGRX) announces a marketing agreement with Marius Pharmaceuticals to launch KYZATREX, an FDA-approved oral Testosterone Replacement Therapy, under the program PRIME by MangoRx. KYZATREX is expected to be available on MangoRx's telemedicine platform starting January 31, 2024. The new therapy aims to address testosterone deficiency in men, with a focus on providing a convenient and effective treatment option.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.54%
Tags
-
Rhea-AI Summary
Mangoceuticals, Inc. (NASDAQ: MGRX) is expanding its sales access across Latin America with the establishment of its subsidiary, MangoRx Mexico, aiming to tap into the Mexican market for men's health and wellness products, particularly its uniquely formulated hair growth product 'GROW' and erectile dysfunction (ED) drug 'Mango'. The company has engaged Diaz Reus International Law Firm for establishing its subsidiary presence in Mexico and is in the process of establishing manufacturing and distribution partnerships. The estimated annual market size in Mexico for ED pharmaceutical products is USD $216 million with approximately 24 million units sold annually and growing at a rate of 4% per year at an average sales price of USD $8.50 per unit.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.2%
Tags
-
News
Rhea-AI Summary
Mangoceuticals, Inc. (NASDAQ: MGRX) announces partnership with TRYBE Labs to provide at-home blood collection services for its men's health and wellness products. The collaboration aims to expand product lines requiring blood tests and results reviewed by physicians, offering innovative, convenient, and minimally invasive solutions for male health and performance evaluation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.61%
Tags
Rhea-AI Summary
Mangoceuticals, Inc. (NASDAQ:MGRX) announces the addition of 'Grow,' a hair growth treatment, to its men's health product line. Combining Minoxidil, Finasteride, Vitamin D3, and Biotin in chewable tablets, the product is available for delivery by prescription through MangoRx's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.38%
Tags
-
Rhea-AI Summary
Mangoceuticals, Inc. (NASDAQ: MGRX) announces that it will donate 50% of proceeds from the sale of its branded merchandise to men's health and wellness charities throughout November. The donations will support education and awareness around prostate cancer, testicular cancer, and men's suicide. Prostate cancer is the second most diagnosed cancer in the US.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.77%
Tags
-
Rhea-AI Summary
Mangoceuticals, Inc. announces the launch of its new TikTok and Instagram Social Media Influencer Initiative, featuring top influencers with large global fan bases. The company aims to deepen its connection with Barstool Sports brand and Glenny Balls, a famous American Podcaster, Blogger, TV personality, and Influencer. MangoRx plans to tap into the powerful audience reach of Glenny Balls to promote the MangoRx brand through the Old Row TikTok account. The company intends to aggressively ramp up its marketing strategy by bringing on new tier-one influencers in the coming weeks.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.53%
Tags
Rhea-AI Summary
Mangoceuticals, Inc. provides updates on its 3rd quarter achievements and future initiatives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
25%
Tags
-
Rhea-AI Summary
Mangoceuticals CEO to be featured on 'New To The Street' TV show
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.59%
Tags
-
Rhea-AI Summary
Mangoceuticals launches affiliate marketing program to drive sales growth
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.03%
Tags
Rhea-AI Summary
MangoRx sponsors Raindance Film Festival, increasing awareness around sexual health and removing stigma around erectile dysfunction. They will host a 60-second short film competition focusing on mental health and ED. MangoRx expands its marketing and branding presence through podcasts and national radio in the US. They have launched their second flagship Mango ED product. Both products are compounded with Oxytocin and L-Arginine and will be shipped discreetly in a master pack of six individually packaged tablets. Partnership with Raindance supports MangoRx's new international market distribution.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.95%
Tags
Mangoceuticals, Inc.
Nasdaq:MGRX
MGRX Rankings
MGRX Stock Data
6.52M
13.19M
41.39%
0.48%
3.01%
Pharmacies and Drug Stores
Retail Trade
United States of America
DALLAS